4.5 Editorial Material

Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide

Related references

Note: Only part of the references are listed.
Article Parasitology

The rule of five should not impede anti-parasitic drug development

James H. McKerrow et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2017)

Article Neurosciences

Why Do So Many Drugs for Alzheimer's Disease Fail in Development? Time for New Methods and New Practices?

Robert E. Becker et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Biotechnology & Applied Microbiology

An analysis of the attrition of drug candidates from four major pharmaceutical companies

Michael J. Waring et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Multidisciplinary Sciences

Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier

Akihiko Urayama et al.

PLoS One (2015)

Article Chemistry, Medicinal

Physiochemical drug properties associated with in vivo toxicological outcomes

Jason D. Hughes et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Article Biotechnology & Applied Microbiology

The influence of drug-like concepts on decision-making in medicinal chemistry

Paul D. Leeson et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Article Immunology

Changing the chemokine gradient: CINC1 crosses the blood-brain barrier

WH Pan et al.

JOURNAL OF NEUROIMMUNOLOGY (2001)